PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Co-amoxiclav - Bacterial infection

PAD Profile : Co-amoxiclav - Bacterial infection

Keywords :
antibiotic, antibacterial, penicillin
Brand Names Include :
Augmentin

Traffic Light Status

Status 1 of 2.

Status :
Green
Important
Formulations :
  • Oral suspension
  • Tablets
Important Information :
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. Follow local guidelines on the use of antimicrobials. Contra-indicated in Penicillin Allergy.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
R
Comments :
No comments returned.
Documents :

Status 2 of 2.

Status :
Red
Important
Formulations :
  • Injection
Important Information :
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Contra-indicated in Penicillin Allergy.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
R
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date
Guidelines (Local)
Antimicrobial Guidelines - Public Health / NICE Summary Tables

Committee Recommendations

Date
Committee Name
Narrative
03 May 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC Co-amoxiclav has been considered by the PCN and has been assigned a GREEN traffic light status. NOTE - the branded product, Augmentin, was considered BLACK at the PCN in May 2017.

Associated BNF Codes

05. Infections
05.01.01. Penicillins
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More